Science Business : The Promise, the Reality, and the Future of Biotech by Gary P. Pisano (2006, Hardcover) online kaufen

Über dieses Produkt

Product Identifiers

PublisherHarvard Business Review Press

ISBN-101591398401

ISBN-139781591398400

eBay Product ID (ePID)53570627

Product Key Features

Book TitleScience Business : the Promise, the Reality, and the Future of Biotech

Number of Pages256 Pages

LanguageEnglish

Publication Year2006

TopicBiotechnology, Leadership

IllustratorYes

GenreScience, Business & Economics

AuthorGary P. Pisano

FormatHardcover

Dimensions

Item Height1 in

Item Weight18.8 Oz

Item Length9.6 in

Item Width6.5 in

Additional Product Features

Intended AudienceTrade

LCCN2006-016541

SynopsisWhy has the biotechnology industry failed to perform up to expectations--despite all its promise? In Science Business , Gary P. Pisano answers this question by providing an incisive critique of the industry. Pisano not only reveals the underlying causes of biotech's problems; he offers the most sophisticated analysis yet on how the industry works. And he provides clear prescriptions for companies, investors, and policy makers seeking ways to improve the industry's performance. According to Pisano, the biotech industry's problems stem from its special character as a science-based business. This character poses three unique business challenges: how to finance highly risky investments under profound uncertainty and long time horizons for R&D, how to learn rapidly enough to keep pace with advances in drug science knowledge, and how to integrate capabilities across a broad spectrum of scientific and technological knowledge bases.The key to fixing the industry? Business models, organisational structures, and financing arrangements that place greater emphasis on integration and long-term learning over shorter--term 'monetisation' of intellectual property. Pisano maintains that all industry players--biotech firms, investors, universities, pharmaceutical companies, government regulators--can play a role in righting the industry. The payoff? Valuable improvements in health care, and a shinier future for human well-being., Why has the biotechnology industry failed to perform up to expectationsdespite all its promise? In Science Business, Gary P. Pisano answers this question by providing an incisive critique of the industry. Pisano not only reveals the underlying causes of biotechs problems; he offers the most sophisticated analysis yet on how the industry works. And he provides clear prescriptions for companies, investors, and policymakers seeking ways to improve the industrys performance.According to Pisano, the biotech industrys problems stem from its special character as a science-based business. This character poses three unique business challenges: 1) how to finance highly risky investments under profound uncertainty and long time horizons for R&D, 2) how to learn rapidly enough to keep pace with advances in drug science knowledge, and 3) how to integrate capabilities across a broad spectrum of scientific and technological knowledge bases. The key to fixing the industry? Business models, organizational structures, and financing arrangements that place greater emphasis on integration and long-term learning over shorter-term monetization of intellectual property. Pisano maintains that all industry playersbiotech firms, investors, universities, pharmaceutical companies, government regulatorscan play a role in righting the industry. The payoff? Valuable improvements in health care, and a shinier future for human well-being.

LC Classification NumberHD9999.B442P57 2006